IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.

Idiopathic nephrotic syndrome is the most frequent pediatric glomerular disease, affecting from 1.15 to 16.9 per 100,000 children per year globally. It is characterized by massive proteinuria, hypoalbuminemia, and/or concomitant edema. Approximately 85–90% of patients attain complete remission of pr...

Descripción completa

Detalles Bibliográficos
Publicado en:Pediatric Nephrology Vol. 38; no. 3; pp. 877 - 920
Autores principales: Trautmann, Agnes, Boyer, Olivia, Hodson, Elisabeth, Bagga, Arvind, Gipson, Debbie S., Samuel, Susan, Wetzels, Jack, Alhasan, Khalid, Banerjee, Sushmita, Bhimma, Rajendra, Bonilla-Felix, Melvin, Cano, Francisco, Christian, Martin, Hahn, Deirdre, Kang, Hee Gyung, Nakanishi, Koichi, Safouh, Hesham, Trachtman, Howard, Xu, Hong, Cook, Wendy
Formato: algorithm research tables/charts Journal Article
Publicado: Springer Nature Mar2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=161327151&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 161327151
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0931041X
        EF1
      jtl: Pediatric Nephrology
      issn: 0931041X
      maglogo: N
    pubinfo:
      dt: Mar2023
      vid: 38
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        161327151
        159782361
        161327151
        161327151
        10.1007/s00467-022-05739-3
        161327151
      ppf: 877
      ppct: 43
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.
      aug:
        au:
          Trautmann, Agnes
          Boyer, Olivia
          Hodson, Elisabeth
          Bagga, Arvind
          Gipson, Debbie S.
          Samuel, Susan
          Wetzels, Jack
          Alhasan, Khalid
          Banerjee, Sushmita
          Bhimma, Rajendra
          Bonilla-Felix, Melvin
          Cano, Francisco
          Christian, Martin
          Hahn, Deirdre
          Kang, Hee Gyung
          Nakanishi, Koichi
          Safouh, Hesham
          Trachtman, Howard
          Xu, Hong
          Cook, Wendy
        affil: Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany
      sug:
        subj:
          Nephrotic Syndrome Diagnosis
          Nephrotic Syndrome Drug Therapy
          Steroids Adverse Effects
          Glucocorticoids Therapeutic Use
          Disease Management
          Recurrence Risk Factors
          Glucocorticoids Administration and Dosage
          Morbidity
          Immunosuppressive Agents
          Medical Practice, Evidence-Based
          Nephrologists
          Treatment Outcomes
          Drug Toxicity
          Practice Guidelines
          Human
          Male
          Female
          Child
          Funding Source
          Child: 6-12 years
          Male
          Female
      ab: Idiopathic nephrotic syndrome is the most frequent pediatric glomerular disease, affecting from 1.15 to 16.9 per 100,000 children per year globally. It is characterized by massive proteinuria, hypoalbuminemia, and/or concomitant edema. Approximately 85–90% of patients attain complete remission of proteinuria within 4–6 weeks of treatment with glucocorticoids, and therefore, have steroid-sensitive nephrotic syndrome (SSNS). Among those patients who are steroid sensitive, 70–80% will have at least one relapse during follow-up, and up to 50% of these patients will experience frequent relapses or become dependent on glucocorticoids to maintain remission. The dose and duration of steroid treatment to prolong time between relapses remains a subject of much debate, and patients continue to experience a high prevalence of steroid-related morbidity. Various steroid-sparing immunosuppressive drugs have been used in clinical practice; however, there is marked practice variation in the selection of these drugs and timing of their introduction during the course of the disease. Therefore, international evidence-based clinical practice recommendations (CPRs) are needed to guide clinical practice and reduce practice variation. The International Pediatric Nephrology Association (IPNA) convened a team of experts including pediatric nephrologists, an adult nephrologist, and a patient representative to develop comprehensive CPRs on the diagnosis and management of SSNS in children. After performing a systematic literature review on 12 clinically relevant PICO (Patient or Population covered, Intervention, Comparator, Outcome) questions, recommendations were formulated and formally graded at several virtual consensus meetings. New definitions for treatment outcomes to help guide change of therapy and recommendations for important research questions are given.
      pubtype: Academic Journal
      doctype:
        algorithm
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N